Platelet Fcγ RIIA: An emerging regulator and biomarker in cardiovascular disease and cancer

被引：2
|
作者：
Zhang, Qingsong [1 ]
Li, Wenxian [1 ]
Mao, Xin [1 ]
Miao, Shuo [2 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Basic Med, Qingdao, Peoples R China
来源：
THROMBOSIS RESEARCH | 2024年 / 238卷
关键词：
Platelet; Fc gamma RIIA; Cardiovascular disease; cancer; MONOCLONAL-ANTIBODIES; RECEPTOR EXPRESSION; IMMUNE-COMPLEXES; IMMUNOGLOBULIN-G; TRANSGENIC MICE; ACTIVATION; THROMBOSIS; COLLAGEN; BINDING; IDENTIFICATION;
D O I：
10.1016/j.thromres.2024.04.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Platelets, anucleate blood cells derive from megakaryocytes, are involved in cardiovascular diseases and tumors. Fc gamma RIIA, the only Fc gamma R expressed on human platelets, is known for its role in immune-related diseases. A growing body of evidence reveals that platelet Fc gamma RIIA is a potential target for the prevention and control of cardiovascular disease and cancer, and is an advantageous biomarker. In this review, we describe the structure and physiological function of platelet Fc gamma RIIA, its regulatory role in cardiovascular disease and cancer, and its potential clinical application.
引用
收藏
页码：19 / 26
页数：8
相关论文
共 50 条
  • [1] The platelet Fc receptor, FcγRIIa
    Qiao, Jianlin
    Al-Tamimi, Mohammad
    Baker, Ross I.
    Andrews, Robert K.
    Gardiner, Elizabeth E.
    IMMUNOLOGICAL REVIEWS, 2015, 268 (01) : 241 - 252
  • [2] Platelet FcγRIIa Expression in Patients With Stable Coronary Artery Disease
    Adamian, Robert
    McCleary, Paul
    Sharma, Toishi
    Schneider, David J.
    JOURNAL OF INVASIVE CARDIOLOGY, 2024, 36 (02):
  • [3] PLATELET FCγRIIA EXPRESSION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Adamian, Robert
    McCleary, Paul
    Sharma, Toishi
    Schneider, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1014 - 1014
  • [4] Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease
    Liebeskind, David S.
    Hinman, Jason D.
    Kaneko, Naoki
    Kitajima, Hiroaki
    Honda, Tristan
    De Havenon, Adam H.
    Feldmann, Edward
    Nogueira, Raul G.
    Prabhakaran, Shyam
    Romano, Jose G.
    Callas, Peter W.
    Schneider, David J.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [5] FcγRIIa A New Cardiovascular Risk Marker
    Schneider, David J.
    McMahon, Sean R.
    Chava, Sreedivya
    Taatjes-Sommer, Heidi S.
    Meagher, Sean
    Ehle, Gregory L.
    Brummel-Ziedins, Kathleen E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (02) : 237 - 238
  • [6] Assessment of Cardiovascular Risk by the Combination of Clinical Risk Scores Plus Platelet Expression of FcγRIIa
    Schneider, David J.
    McMahon, Sean R.
    Ehle, Gregory L.
    Chava, Sreedivya
    Taatjes-Sommer, Heidi S.
    Meagher, Sean
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (05): : 670 - 672
  • [7] Platelet FcγRIIA in immunity and thrombosis: Adaptive immunothrombosis
    Patel, Pravin
    Michael, James V.
    Naik, Ulhas P.
    McKenzie, Steven E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1149 - 1160
  • [8] Platelet FcγRIIA signaling: new clues for HIT
    Assinger, Alice
    BLOOD, 2015, 126 (26) : 2777 - 2778
  • [9] The association between platelet activation and FcγRIIa proteolysis
    Nazi, I.
    Smith, J. W.
    Arnold, D. M.
    Horsewood, P.
    Moore, J. C.
    Warkentin, T. E.
    Kelton, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) : 885 - 887
  • [10] A novel and essential role for FcγRIIa in cancer cell-induced platelet activation
    Mitrugno, Annachiara
    Williams, David
    Kerrigan, Steven W.
    Moran, Niamh
    BLOOD, 2014, 123 (02) : 249 - 260
12345